Logistic regression analysis of mRNA expression changes and prognosis after cervical surgery
Source abstract
Abstract
Objective: The aim of this study was to investigate the diagnostic value of HPV (human papillomavirus) E6/E7 mRNA combined with thin-layer liquid-based cytology test (TCT) detection in patients with cervical intraepithelial neoplasia (CIN) in the residual and recurrence of lesions after cervical conization. Methods: A total of 154 patients who had undergone cervical conization and were diagnosed with high-grade cervical intraepithelial neoplasia (CIN 1 and CIN 3) by histopathology and had complete follow-up data were enrolled. TCT, HPV-DNA detection, and HPV E6/E7 mRNA detection combined with TCT detection in 12 months can be used to detect abnormal cytology (>atypical squamous epithelium of undetermined significance). Patients with atypical squamous cell of undetermined significance or high-risk HPV-DNA (+) or HPV E6/E7 mRNA combined with TCT (+) underwent colposcopy and cervical biopsy again for pathological diagnosis. Results: There were 9 cases of residual lesions and 22 cases of recurrence. Thirty of the 57 cases with positive HPV-DNA after surgery were still there or came back. Of the 26 cases with positive HPV E6/E7 mRNA combined with TCT, 24 were still there or came back. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy rate of HPV-DNA detection were 96.8%, 78.0%, 52.6%, 99.0%, and 81.8%, respectively; the sensitivity and specificity of HPV E6/E7 mRNA were combined with TCT detection of sex. Conclusion: HPV E6/E7 mRNA combined with TCT detection can be included in follow-up examinations, which can timely and effectively predict the risk of CIN residual or recurrence after cervical conization and reduce excessive examination and treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cancer-related molecular mechanisms research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Gynecological Clinic, Cangzhou Central Hospital , CangZhou 061000, China
Funding
Cangzhou Key Research and Development Projects
References (27)
Show source-provided references
1. The role of the cervicovaginal microbiome on the genesis and as a biomarker of premalignant cervical intraepithelial neoplasia and invasive cervical cancer10.3390/ijms21010222 ↗
2. Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: A systematic review and meta-analysis of the literature10.1016/j.annonc.2019.11.004 ↗
3. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia10.1186/s13027-019-0243-8 ↗
4. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions10.1038/s41467-020-15856-y ↗
5. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: The HPV FOCAL randomized clinical trial10.1001/jama.2018.7464 ↗
6. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): A systematic review and meta-analysis10.1038/s41416-019-0593-4 ↗
7. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: A meta-analysis10.1007/s00404-020-05787-w ↗
8. Advances in therapeutic vaccines for treating human papillomavirus-related cervical intraepithelial neoplasia10.1111/jog.14276 ↗
9. The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia10.1002/cam4.1471 ↗
10. The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: A systematic review and meta-analysis10.1097/lgt.0000000000000604 ↗
11. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: A review10.1111/1471-0528.16395 ↗
12. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia10.1093/cid/ciz677 ↗
13. Associations of cervicovaginal lactobacilli with high-risk human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: A systematic review and meta-analysis10.1093/infdis/jiz325 ↗
14. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning10.1136/jmedgenet-2018-105745 ↗
15. Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: A narrative review10.1016/j.gore.2020.100608 ↗
16. Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study10.1093/cid/ciz239 ↗
17. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer10.1002/1878-0261.12383 ↗
18. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study10.1016/j.ygyno.2020.07.099 ↗
19. Pregnancy outcomes in women with a prior cervical intraepithelial neoplasia grade 3 diagnosis: A nationwide population-based cohort study with sibling comparison design10.7326/m21-2793 ↗
20. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort10.1186/s12879-020-05324-9 ↗
21. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: Results from large cohort, systematic review, meta-analysis10.1038/s41598-018-24882-2 ↗
22. HPV vaccination as adjuvant to conization in women with cervical intraepithelial neoplasia: A study under real-life conditions10.3390/vaccines8020245 ↗
23. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease—A 16-year follow-up study10.1016/j.ajog.2019.08.042 ↗
24. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2–3 after treatment with a large loop excision of the transformation zone: A retrospective study10.1111/1471-0528.15996 ↗
25. Noninvasive physical plasma as innovative and tissue-preserving therapy for women positive for cervical intraepithelial neoplasia10.3390/cancers14081933 ↗
26. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer10.1056/nejmoa1804923 ↗
27. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer10.1016/j.tranon.2023.101839 ↗